Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response after Shingrix vaccination in healthy adults
2025-521547-20-00Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Centre Hospitalier Universitaire de Liège. Started Jun 2026; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2025-521547-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521547-20-00.